Siraki Arno G, Chevaldina Tatiana, O'Brien Peter J
Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, Ont., Canada M5S 2S2.
Chem Biol Interact. 2005 Feb 10;151(3):177-91. doi: 10.1016/j.cbi.2004.12.006. Epub 2005 Jan 21.
Non-steroidal anti-inflammatory agents (NSAIDs) are widely used for pain relief. However, they have been associated with harmful and sometimes fatal side effects. Usually, the target organs are the GI tract and liver. In this study, we have investigated the physicochemical requirements of 21 NSAIDs for glucuronidation and cytotoxicity by quantitative structure-toxicity relationships (QSTRs) in isolated rat hepatocytes. Furthermore, we have investigated the contrast in physicochemical variables that correlated with NSAID-induced hepatocyte cytotoxicity when glucuronidation was inhibited with borneol. The competitive inhibition of hepatocyte p-nitrophenol glucuronidation by NSAIDs was determined by HPLC. Glucuronidation-inhibited hepatocytes were more susceptible to NSAID-induced cytotoxicity. Also, we found a parabolic correlation between lipophilicity and the inhibition of glucuronidation for a subset of NSAIDs. For NSAIDs with a benzoic acid moiety, cytotoxicity also correlated parabolically with lipophilicity, but correlated linearly with the HOMO-LUMO gap, and the first-order valence connectivity index. The cytotoxicity of NSAIDs with a phenylacetic acid (or propionic acid) substructure also correlated with lipophilicity, but not with the HOMO-LUMO gap. Our findings indicated that the inhibition of glucuronidation resulted in increased NSAID cytotoxicity, suggesting that acyl-glucuronide metabolites were acutely less cytotoxic. Also, comparative QSTRs revealed that benzoic acid NSAIDs may form cytotoxic radical metabolites (parameterized by the HOMO-LUMO gap) or alter mitochondrial respiration (parameterized by the connectivity index), whereas phenylacetic acid derived NSAIDs may form different cytotoxic metabolites, since they did not correlate with these parameters. In summary, we have used QSTRs as a tool to distinguish the cytotoxic mechanism of two groups of NSAIDs, which, if analyzed together as one group, did not reveal such mechanism-based differences.
非甾体抗炎药(NSAIDs)被广泛用于缓解疼痛。然而,它们与有害甚至有时致命的副作用有关。通常,靶器官是胃肠道和肝脏。在本研究中,我们通过定量结构-毒性关系(QSTRs)研究了21种NSAIDs在离体大鼠肝细胞中进行葡萄糖醛酸化和细胞毒性的物理化学要求。此外,我们还研究了用冰片抑制葡萄糖醛酸化时,与NSAIDs诱导的肝细胞毒性相关的物理化学变量的差异。通过高效液相色谱法测定NSAIDs对肝细胞对硝基苯酚葡萄糖醛酸化的竞争性抑制作用。葡萄糖醛酸化受抑制的肝细胞对NSAIDs诱导的细胞毒性更敏感。此外,我们发现对于一部分NSAIDs,亲脂性与葡萄糖醛酸化抑制之间存在抛物线相关性。对于含有苯甲酸部分的NSAIDs,细胞毒性也与亲脂性呈抛物线相关,但与最高占据分子轨道-最低未占据分子轨道(HOMO-LUMO)能隙以及一阶价连接性指数呈线性相关。具有苯乙酸(或丙酸)亚结构的NSAIDs的细胞毒性也与亲脂性相关,但与HOMO-LUMO能隙无关。我们的研究结果表明,葡萄糖醛酸化的抑制导致NSAIDs细胞毒性增加,这表明酰基葡萄糖醛酸代谢物的细胞毒性明显较低。此外,比较QSTRs显示,苯甲酸类NSAIDs可能形成细胞毒性自由基代谢物(由HOMO-LUMO能隙参数化)或改变线粒体呼吸(由连接性指数参数化),而苯乙酸衍生的NSAIDs可能形成不同的细胞毒性代谢物,因为它们与这些参数无关。总之,我们使用QSTRs作为工具来区分两组NSAIDs的细胞毒性机制,如果将它们作为一组进行分析,则不会揭示这种基于机制的差异。